Exchange
SIX
Every company in the roster listed on SIX.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
2 of 2 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Sandoz Group AGSDZ · SIX | 5 assets: 5 approved | Approved assets only | 4 Feb 2027Ranibizumab · Phase 3 |
 Idorsia PharmaceuticalsIDIA · SIX | 1 asset: 1 approved | Approved assets only | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).